Biopolymeric Mucin and Synthetic Polymer Analogs: Their Structure, Function and Role in Biomedical Applications

被引:58
作者
Authimoolam, Sundar P. [1 ]
Dziubla, Thomas D. [1 ]
机构
[1] Univ Kentucky, Dept Chem & Mat Engn, Coll Engn, 177 Paul Anderson Tower, Lexington, KY 40506 USA
基金
美国国家卫生研究院;
关键词
tissue engineering; polymer analog; mucin; bioapplication; drug delivery; polymer networks; biomimic; SALIVARY-BACTERIAL INTERACTIONS; HUMAN CERVICOVAGINAL MUCUS; HUMAN CERVICAL-MUCUS; DRUG-DELIVERY; MUCOADHESIVE POLYMERS; GASTROINTESTINAL MUCUS; STREPTOCOCCUS-SANGUIS; ARTIFICIAL SALIVA; MUCOSAL PELLICLE; ANTICANDIDAL ACTIVITY;
D O I
10.3390/polym8030071
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Mucin networks are viscoelastic fibrillar aggregates formed through the complex self-association of biopolymeric glycoprotein chains. The networks form a lubricious, hydrated protective shield along epithelial regions within the human body. The critical role played by mucin networks in impacting the transport properties of biofunctional molecules (e.g., biogenic molecules, probes, nanoparticles), and its effect on bioavailability are well described in the literature. An alternate perspective is provided in this paper, presenting mucin's complex network structure, and its interdependent functional characteristics in human physiology. We highlight the recent advances that were achieved through the use of mucin in diverse areas of bioengineering applications (e.g., drug delivery, biomedical devices and tissue engineering). Mucin network formation is a highly complex process, driven by wide variety of molecular interactions, and the network possess structural and chemical variations, posing a great challenge to understand mucin's bulk behavior. Through this review, the prospective potential of polymer based analogs to serve as mucin mimic is suggested. These analog systems, apart from functioning as an artificial model, reducing the current dependency on animal models, can aid in furthering our fundamental understanding of such complex structures.
引用
收藏
页数:28
相关论文
共 220 条
  • [1] Defining the normal bacterial flora of the oral cavity
    Aas, JA
    Paster, BJ
    Stokes, LN
    Olsen, I
    Dewhirst, FE
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (11) : 5721 - 5732
  • [2] Acarturk Fusun, 2009, Recent Pat Drug Deliv Formul, V3, P193
  • [3] Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus
    Adebisi, Adeola O.
    Conway, Barbara R.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 470 (1-2) : 28 - 40
  • [4] CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells
    Aigner, S
    Sthoeger, ZM
    Fogel, M
    Weber, E
    Zarn, J
    Ruppert, M
    Zeller, Y
    Vestweber, D
    Stahel, R
    Sammar, M
    Altevogt, P
    [J]. BLOOD, 1997, 89 (09) : 3385 - 3395
  • [5] Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery
    Alipour, Shohreh
    Montaseri, Hashem
    Tafaghodi, Mohsen
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2010, 81 (02) : 521 - 529
  • [6] THE MUCUS BARRIER - ITS ROLE IN GASTRODUODENAL MUCOSAL PROTECTION
    ALLEN, A
    LEONARD, AJ
    SELLERS, LA
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1988, 10 : S93 - S98
  • [7] Gastroduodenal mucus bicarbonate barrier:: protection against acid and pepsin
    Allen, A
    Flemström, G
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2005, 288 (01): : C1 - C19
  • [8] GASTRODUODENAL MUCOSAL PROTECTION
    ALLEN, A
    FLEMSTROM, G
    GARNER, A
    KIVILAAKSO, E
    [J]. PHYSIOLOGICAL REVIEWS, 1993, 73 (04) : 823 - 857
  • [9] Probiotics for treating acute infectious diarrhoea
    Allen, Stephen J.
    Martinez, Elizabeth G.
    Gregorio, Germana V.
    Dans, Leonila F.
    [J]. SAO PAULO MEDICAL JOURNAL, 2011, 129 (03): : 185 - 185
  • [10] Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery
    Alpar, HO
    Somavarapu, S
    Atuah, KN
    Bramwell, V
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (03) : 411 - 430